Ovarian Cancer Therapy by VSVMP Gene Mediated by a Paclitaxel-Enhanced Nanoparticle-Reference-Cited by-同舟云学术

Ovarian Cancer Therapy by VSVMP Gene Mediated by a Paclitaxel-Enhanced Nanoparticle

Published:2017-11-03 Issue:45 Volume:9 Page:39152-39164
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Long Jianlin¹²³⁴,Yang Yuping¹³,Kang Tianyi¹³,Zhao Wei¹³,Cheng Hao¹³,Wu Yujiao¹³,Du Ting¹³,Liu Beibei¹³,Li Yang¹³,Luo Feng¹²³,Gou Maling¹³^ORCID

Affiliation:

1. State Key Laboratory of Biotherapy and cancer center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, 610041, P.R. China

2. Department of Medical Oncology, Lung Cancer Center, Cancer Center, West China Hospital, Medical School, Sichuan University, Chengdu, Sichuan 610041, P. R. China

3. Collaborative Innovation Center for Biotherapy, Chengdu, Sichuan 610041, P. R. China

4. Department of Oncology, West China Guang’an Hospital, Sichuan University, Guang’an, Sichuan 638000, P. R. China

Funder

Department of Science and Technology of Sichuan Province

National Natural Science Foundation of China

Foundation for Distinguished Young Scientists of Sichuan Province

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.7b10796